Oxford AstraZeneca vaccine to be sold to developing countries at cost price

Jab that is part of global initiative to distribute doses will remain at low price in perpetuity'

• Coronavirus - latest updates
• See all our coronavirus coverage

The coronavirus vaccine produced by Oxford University and AstraZeneca will be available on a non-profit basis in perpetuity" to low- and middle-income countries in the developing world.

The details of arrangements to supply poorer countries came as AstraZeneca revealed the interim results of a phase 3 trial of the vaccine, which is being heralded as the first to meet the more challenging requirements of the developing world.